Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Altria Group Inc MO

Altria Group, Inc. is a holding company that provides a portfolio of tobacco products for United States tobacco consumers aged 21+. The Company operates through two segments: smokeable tobacco products and oral tobacco products. The smokeable tobacco products consist of combustible cigarettes manufactured and sold by Philip Morris USA Inc. (PM USA ), and machine-made large cigars and pipe tobacco manufactured and sold by John Middleton Co. (Middleton). The oral tobacco products consist of moist smokeless tobacco (MST) and snus products manufactured and sold by U.S. Smokeless Tobacco Company LLC (USSTC), and oral nicotine pouches manufactured and sold by Helix Innovations LLC (Helix). The Company’s e-vapor products are marketed by NJOY, LLC (NJOY), a wholly owned subsidiary of the Company. The Company’s brand portfolio of its tobacco operating companies include Marlboro, Black & Mild, Copenhagen, Skoal, on! and NJOY ACE.


NYSE:MO - Post by User

<< Previous
Bullboard Posts
User Avatar Image
(11)
•••
  • WrywisdomX
Post by Wrywisdomon Aug 10, 2022 3:23pm
94 Views
Post# 34886030

Incredible Value. ENTG at about 25% of One Years Revenue

Incredible Value. ENTG at about 25% of One Years Revenue.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:

                   https://stockhouse.com/news/press-releases/2022/05/30/entourage-health-reports-record-first-quarter-2022-financial-results

Notwithstanding all of the prior major achievements getting us to this point, just within the past few weeks:

           -unlike so many cannabis counterparts, ENTG has shored up high level financing guaranteed for more than 2 years with no dilution, and dramatically reduces convertible debentures:

                   https://stockhouse.com/news/press-releases/2022/07/29/entourage-health-provides-update-on-credit-facilities-maturity-dates-and-amends

           -Further expands medical offerings with new products and services:

                   tockhouse.com/news/press-releases/2022/07/26/entourage-expands-medical-offerings-with-launch-of-new-services-and-products

          -Announces and exclusive Canadian licensing deal to distribute a broad range of Irwin Naturals cannabis Products:

                   https://stockhouse.com/news/press-releases/2022/08/04/irwin-naturals-cannabis-products-to-be-available-in-canada

          
...and will be introducting groundbreaking Boston Beer/Samuel Adams products at any time now:
            https://stockhouse.com/news/press-releases/2022/05/23/the-boston-beer-company-introduces-teapot-a-new-line-of-cannabis-infused-iced

         
Simply an unrivaled value, period. 
What a truly extraordinary opportunity here particularly for new investors but again, also for those seeking to cost average as well.
<< Previous
Bullboard Posts